2018
DOI: 10.1111/ijd.14141
|View full text |Cite
|
Sign up to set email alerts
|

An effective and promising treatment with adalimumab for impetigo herpetiformis with postpartum flare-up

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 14 publications
0
8
0
Order By: Relevance
“…[4][5][6][7][8][9][10][11][12] Among 10 IH patients of East Asian descent, seven had Summary of impetigo herpetiformis patients and IL36RN mutations…”
mentioning
confidence: 99%
“…[4][5][6][7][8][9][10][11][12] Among 10 IH patients of East Asian descent, seven had Summary of impetigo herpetiformis patients and IL36RN mutations…”
mentioning
confidence: 99%
“…The literature search identified 83 articles, only 35 were ultimately selected 5–39 . The corresponding results are summarized in Table 2.…”
Section: Resultsmentioning
confidence: 99%
“…In the review of the literature, the use of additional treatments like Granulocyte, monocyte adsorptive apheresis (GMA or GCAP) was reported and controlled the disease 8,15,18,20,22,28,47 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover, some studies have suggested that tumour necrosis factor-alpha inhibitor (TNFi) may be effective for severe PPP. Infliximab and adalimumab have been shown to improve health conditions in patients with resistant PPP ( 6 , 7 ). However, these drugs may increase the risk of pustular psoriasis ( 8 ).…”
Section: Discussionmentioning
confidence: 99%